According to this latest study, the 2021 growth of OTC Anti-Infective Products will have significant change from previous year. By the most conservative estimates of global OTC Anti-Infective Products market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ 12740 million in 2020. Over the next five years the OTC Anti-Infective Products market will register a 3.5% CAGR in terms of revenue, the global market size will reach US$ 14630 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of OTC Anti-Infective Products market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
- Antifungal
- Antibacterial
- Antiviral
- Antiseptics
- Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
- Bayer
- GSK
- Teva
- Johnson & Johnson
- NOVARTIS
- MYLAN
- Sun Pharma
- CR SANJIU
- Cipla
- Lingrui
Global OTC Anti-Infective Products Market Growth 2021-2026
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global OTC Anti-Infective Products Consumption 2016-2026
2.1.2 OTC Anti-Infective Products Consumption CAGR by Region
2.2 OTC Anti-Infective Products Segment by Type
2.2.1 Antifungal
2.2.2 Antibacterial
2.2.3 Antiviral
2.2.4 Antiseptics
2.2.5 Others
2.3 OTC Anti-Infective Products Sales by Type
2.3.1 Global OTC Anti-Infective Products Sales Market Share by Type (2016-2021)
2.3.2 Global OTC Anti-Infective Products Revenue and Market Share by Type (2016-2021)
2.3.3 Global OTC Anti-Infective Products Sale Price by Type (2016-2021)
2.4 OTC Anti-Infective Products Segment by Sales Channel
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 OTC Anti-Infective Products Sales by Sales Channel
2.5.1 Global OTC Anti-Infective Products Sale Market Share by Sales Channel (2016-2021)
2.5.2 Global OTC Anti-Infective Products Revenue and Market Share by Sales Channel (2016-2021)
2.5.3 Global OTC Anti-Infective Products Sale Price by Sales Channel (2016-2021)
3 Global OTC Anti-Infective Products by Company
3.1 Global OTC Anti-Infective Products Sales Market Share by Company
3.1.1 Global OTC Anti-Infective Products Sales by Company (2019-2021)
3.1.2 Global OTC Anti-Infective Products Sales Market Share by Company (2019-2021)
3.2 Global OTC Anti-Infective Products Revenue Market Share by Company
3.2.1 Global OTC Anti-Infective Products Revenue by Company (2019-2021)
3.2.2 Global OTC Anti-Infective Products Revenue Market Share by Company (2019-2021)
3.3 Global OTC Anti-Infective Products Sale Price by Company
3.4 Global Manufacturers OTC Anti-Infective Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers OTC Anti-Infective Products Product Location Distribution
3.4.2 Players OTC Anti-Infective Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 OTC Anti-Infective Products by Region
4.1 Global OTC Anti-Infective Products by Region
4.1.1 Global OTC Anti-Infective Products Sales by Region
4.1.2 Global OTC Anti-Infective Products Revenue by Region
4.2 Americas OTC Anti-Infective Products Sales Growth
4.3 APAC OTC Anti-Infective Products Sales Growth
4.4 Europe OTC Anti-Infective Products Sales Growth
4.5 Middle East & Africa OTC Anti-Infective Products Sales Growth
5 Americas
5.1 Americas OTC Anti-Infective Products Sales by Country
5.1.1 Americas OTC Anti-Infective Products Sales by Country (2016-2021)
5.1.2 Americas OTC Anti-Infective Products Revenue by Country (2016-2021)
5.2 Americas OTC Anti-Infective Products Sales by Type
5.3 Americas OTC Anti-Infective Products Sales by Sales Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC Anti-Infective Products Sales by Region
6.1.1 APAC OTC Anti-Infective Products Sales by Region (2016-2021)
6.1.2 APAC OTC Anti-Infective Products Revenue by Region (2016-2021)
6.2 APAC OTC Anti-Infective Products Sales by Type
6.3 APAC OTC Anti-Infective Products Sales by Sales Channel
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe OTC Anti-Infective Products by Country
7.1.1 Europe OTC Anti-Infective Products Sales by Country (2016-2021)
7.1.2 Europe OTC Anti-Infective Products Revenue by Country (2016-2021)
7.2 Europe OTC Anti-Infective Products Sales by Type
7.3 Europe OTC Anti-Infective Products Sales by Sales Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa OTC Anti-Infective Products by Country
8.1.1 Middle East & Africa OTC Anti-Infective Products Sales by Country (2016-2021)
8.1.2 Middle East & Africa OTC Anti-Infective Products Revenue by Country (2016-2021)
8.2 Middle East & Africa OTC Anti-Infective Products Sales by Type
8.3 Middle East & Africa OTC Anti-Infective Products Sales by Sales Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 OTC Anti-Infective Products Distributors
10.3 OTC Anti-Infective Products Customer
11 Global OTC Anti-Infective Products Market Forecast
11.1 Global OTC Anti-Infective Products Forecast by Region
11.1.1 Global OTC Anti-Infective Products Forecast by Regions (2021-2026)
11.2.2 Global OTC Anti-Infective Products Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global OTC Anti-Infective Products Forecast by Type
11.7 Global OTC Anti-Infective Products Forecast by Sales Channel
12 Key Players Analysis
12.1 Bayer
12.1.1 Bayer Company Information
12.1.2 Bayer OTC Anti-Infective Products Product Offered
12.1.3 Bayer OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Bayer Main Business Overview
12.1.5 Bayer Latest Developments
12.2 GSK
12.2.1 GSK Company Information
12.2.2 GSK OTC Anti-Infective Products Product Offered
12.2.3 GSK OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GSK Main Business Overview
12.2.5 GSK Latest Developments
12.3 Teva
12.3.1 Teva Company Information
12.3.2 Teva OTC Anti-Infective Products Product Offered
12.3.3 Teva OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Teva Main Business Overview
12.3.5 Teva Latest Developments
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Information
12.4.2 Johnson & Johnson OTC Anti-Infective Products Product Offered
12.4.3 Johnson & Johnson OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Johnson & Johnson Main Business Overview
12.4.5 Johnson & Johnson Latest Developments
12.5 NOVARTIS
12.5.1 NOVARTIS Company Information
12.5.2 NOVARTIS OTC Anti-Infective Products Product Offered
12.5.3 NOVARTIS OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 NOVARTIS Main Business Overview
12.5.5 NOVARTIS Latest Developments
12.6 MYLAN
12.6.1 MYLAN Company Information
12.6.2 MYLAN OTC Anti-Infective Products Product Offered
12.6.3 MYLAN OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 MYLAN Main Business Overview
12.6.5 MYLAN Latest Developments
12.7 Sun Pharma
12.7.1 Sun Pharma Company Information
12.7.2 Sun Pharma OTC Anti-Infective Products Product Offered
12.7.3 Sun Pharma OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Sun Pharma Main Business Overview
12.7.5 Sun Pharma Latest Developments
12.8 CR SANJIU
12.8.1 CR SANJIU Company Information
12.8.2 CR SANJIU OTC Anti-Infective Products Product Offered
12.8.3 CR SANJIU OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 CR SANJIU Main Business Overview
12.8.5 CR SANJIU Latest Developments
12.9 Cipla
12.9.1 Cipla Company Information
12.9.2 Cipla OTC Anti-Infective Products Product Offered
12.9.3 Cipla OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Cipla Main Business Overview
12.9.5 Cipla Latest Developments
12.10 Lingrui
12.10.1 Lingrui Company Information
12.10.2 Lingrui OTC Anti-Infective Products Product Offered
12.10.3 Lingrui OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Lingrui Main Business Overview
12.10.5 Lingrui Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. OTC Anti-Infective Products Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Antifungal
Table 3. Major Players of Antibacterial
Table 4. Major Players of Antiviral
Table 5. Major Players of Antiseptics
Table 6. Major Players of Others
Table 7. Global OTC Anti-Infective Products Sales by Type (2016-2021) & (M Units)
Table 8. Global OTC Anti-Infective Products Sales Market Share by Type (2016-2021)
Table 9. Global OTC Anti-Infective Products Revenue by Type (2016-2021) & ($ million)
Table 10. Global OTC Anti-Infective Products Revenue Market Share by Type (2016-2021)
Table 11. Global OTC Anti-Infective Products Sale Price by Type (2016-2021)
Table 12. Global OTC Anti-Infective Products Sales by Sales Channel (2016-2021) & (M Units)
Table 13. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2016-2021)
Table 14. Global OTC Anti-Infective Products Value by Sales Channel (2016-2021)
Table 15. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2016-2021)
Table 16. Global OTC Anti-Infective Products Sale Price by Sales Channel (2016-2021)
Table 17. Global OTC Anti-Infective Products Sales by Company (2019-2021) & (M Units)
Table 18. Global OTC Anti-Infective Products Sales Market Share by Company (2019-2021)
Table 19. Global OTC Anti-Infective Products Revenue by Company (2019-2021) ($ Millions)
Table 20. Global OTC Anti-Infective Products Revenue Market Share by Company (2019-2021)
Table 21. Global OTC Anti-Infective Products Sale Price by Company (2019-2021)
Table 22. Key Manufacturers OTC Anti-Infective Products Producing Area Distribution and Sales Area
Table 23. Players OTC Anti-Infective Products Products Offered
Table 24. OTC Anti-Infective Products Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global OTC Anti-Infective Products Sales by Region (2016-2021) (M Units)
Table 28. Global OTC Anti-Infective Products Sales Market Share by Region (2016-2021)
Table 29. Global OTC Anti-Infective Products Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global OTC Anti-Infective Products Revenue Market Share by Region (2016-2021)
Table 31. Americas OTC Anti-Infective Products Sales by Country (2016-2021) & (M Units)
Table 32. Americas OTC Anti-Infective Products Sales Market Share by Country (2016-2021)
Table 33. Americas OTC Anti-Infective Products Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas OTC Anti-Infective Products Revenue Market Share by Country (2016-2021)
Table 35. Americas OTC Anti-Infective Products Sales by Type (2016-2021) & (M Units)
Table 36. Americas OTC Anti-Infective Products Sales Market Share by Type (2016-2021)
Table 37. Americas OTC Anti-Infective Products Sales by Sales Channel (2016-2021) & (M Units)
Table 38. Americas OTC Anti-Infective Products Sales Market Share by Sales Channel (2016-2021)
Table 39. APAC OTC Anti-Infective Products Sales by Region (2016-2021) & (M Units)
Table 40. APAC OTC Anti-Infective Products Sales Market Share by Region (2016-2021)
Table 41. APAC OTC Anti-Infective Products Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC OTC Anti-Infective Products Revenue Market Share by Region (2016-2021)
Table 43. APAC OTC Anti-Infective Products Sales by Type (2016-2021) & (M Units)
Table 44. APAC OTC Anti-Infective Products Sales Market Share by Type (2016-2021)
Table 45. APAC OTC Anti-Infective Products Sales by Sales Channel (2016-2021) & (M Units)
Table 46. APAC OTC Anti-Infective Products Sales Market Share by Sales Channel (2016-2021)
Table 47. Europe OTC Anti-Infective Products Sales by Country (2016-2021) & (M Units)
Table 48. Europe OTC Anti-Infective Products Sales Market Share by Country (2016-2021)
Table 49. Europe OTC Anti-Infective Products Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe OTC Anti-Infective Products Revenue Market Share by Country (2016-2021)
Table 51. Europe OTC Anti-Infective Products Sales by Type (2016-2021) & (M Units)
Table 52. Europe OTC Anti-Infective Products Sales Market Share by Type (2016-2021)
Table 53. Europe OTC Anti-Infective Products Sales by Sales Channel (2016-2021) & (M Units)
Table 54. Europe OTC Anti-Infective Products Sales Market Share by Sales Channel (2016-2021)
Table 55. Middle East & Africa OTC Anti-Infective Products Sales by Country (2016-2021) & (M Units)
Table 56. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa OTC Anti-Infective Products Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa OTC Anti-Infective Products Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa OTC Anti-Infective Products Sales by Type (2016-2021) & (M Units)
Table 60. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa OTC Anti-Infective Products Sales by Sales Channel (2016-2021) & (M Units)
Table 62. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Sales Channel (2016-2021)
Table 63. Key and Potential Regions of OTC Anti-Infective Products
Table 64. Key Application and Potential Industries of OTC Anti-Infective Products
Table 65. Key Challenges of OTC Anti-Infective Products
Table 66. Key Trends of OTC Anti-Infective Products
Table 67. OTC Anti-Infective Products Distributors List
Table 68. OTC Anti-Infective Products Customer List
Table 69. Global OTC Anti-Infective Products Sales Forecast by Region (2021-2026) & (M Units)
Table 70. Global OTC Anti-Infective Products Consumption Market Forecast by Region
Table 71. Global OTC Anti-Infective Products Revenue Forecast by Region (2021-2026) & ($ millions)
Table 72. Global OTC Anti-Infective Products Revenue Market Share Forecast by Region (2021-2026)
Table 73. Americas OTC Anti-Infective Products Sales Forecast by Country (2021-2026) & (M Units)
Table 74. Americas OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) & ($ millions)
Table 75. APAC OTC Anti-Infective Products Sales Forecast by Region (2021-2026) & (M Units)
Table 76. APAC OTC Anti-Infective Products Revenue Forecast by Region (2021-2026) & ($ millions)
Table 77. Europe OTC Anti-Infective Products Sales Forecast by Country (2021-2026) & (M Units)
Table 78. Europe OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Middle East & Africa OTC Anti-Infective Products Sales Forecast by Country (2021-2026) & (M Units)
Table 80. Middle East & Africa OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) & ($ millions)
Table 81. Global OTC Anti-Infective Products Sales Forecast by Type (2021-2026) & (M Units)
Table 82. Global OTC Anti-Infective Products Sales Market Share Forecast by Type (2021-2026)
Table 83. Global OTC Anti-Infective Products Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 84. Global OTC Anti-Infective Products Revenue Market Share Forecast by Type (2021-2026)
Table 85. Global OTC Anti-Infective Products Sales Forecast by Sales Channel (2021-2026) & (M Units)
Table 86. Global OTC Anti-Infective Products Sales Market Share Forecast by Sales Channel (2021-2026)
Table 87. Global OTC Anti-Infective Products Revenue Forecast by Sales Channel (2021-2026) & ($ Millions)
Table 88. Global OTC Anti-Infective Products Revenue Market Share Forecast by Sales Channel (2021-2026)
Table 89. Bayer Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 90. Bayer OTC Anti-Infective Products Product Offered
Table 91. Bayer OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 92. Bayer Main Business
Table 93. Bayer Latest Developments
Table 94. GSK Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 95. GSK OTC Anti-Infective Products Product Offered
Table 96. GSK OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 97. GSK Main Business
Table 98. GSK Latest Developments
Table 99. Teva Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 100. Teva OTC Anti-Infective Products Product Offered
Table 101. Teva OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 102. Teva Main Business
Table 103. Teva Latest Developments
Table 104. Johnson & Johnson Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 105. Johnson & Johnson OTC Anti-Infective Products Product Offered
Table 106. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 107. Johnson & Johnson Main Business
Table 108. Johnson & Johnson Latest Developments
Table 109. NOVARTIS Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 110. NOVARTIS OTC Anti-Infective Products Product Offered
Table 111. NOVARTIS OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 112. NOVARTIS Main Business
Table 113. NOVARTIS Latest Developments
Table 114. MYLAN Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 115. MYLAN OTC Anti-Infective Products Product Offered
Table 116. MYLAN OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 117. MYLAN Main Business
Table 118. MYLAN Latest Developments
Table 119. Sun Pharma Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 120. Sun Pharma OTC Anti-Infective Products Product Offered
Table 121. Sun Pharma OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 122. Sun Pharma Main Business
Table 123. Sun Pharma Latest Developments
Table 124. CR SANJIU Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 125. CR SANJIU OTC Anti-Infective Products Product Offered
Table 126. CR SANJIU OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 127. CR SANJIU Main Business
Table 128. CR SANJIU Latest Developments
Table 129. Cipla Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 130. Cipla OTC Anti-Infective Products Product Offered
Table 131. Cipla OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 132. Cipla Main Business
Table 133. Cipla Latest Developments
Table 134. Lingrui Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 135. Lingrui OTC Anti-Infective Products Product Offered
Table 136. Lingrui OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 137. Lingrui Main Business
Table 138. Lingrui Latest Developments
List of Figures
Figure 1. Picture of OTC Anti-Infective Products
Figure 2. OTC Anti-Infective Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global OTC Anti-Infective Products Sales Growth Rate 2016-2026 (M Units)
Figure 7. Global OTC Anti-Infective Products Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. OTC Anti-Infective Products Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Antifungal
Figure 10. Product Picture of Antibacterial
Figure 11. Product Picture of Antiviral
Figure 12. Product Picture of Antiseptics
Figure 13. Product Picture of Others
Figure 14. Global OTC Anti-Infective Products Sales Market Share by Type in 2020
Figure 15. Global OTC Anti-Infective Products Revenue Market Share by Type (2016-2021)
Figure 16. OTC Anti-Infective Products Consumed in Hospital Pharmacies
Figure 17. Global OTC Anti-Infective Products Market: Hospital Pharmacies (2016-2021) & (M Units)
Figure 18. OTC Anti-Infective Products Consumed in Retail Pharmacies
Figure 19. Global OTC Anti-Infective Products Market: Retail Pharmacies (2016-2021) & (M Units)
Figure 20. OTC Anti-Infective Products Consumed in Online Pharmacies
Figure 21. Global OTC Anti-Infective Products Market: Online Pharmacies (2016-2021) & (M Units)
Figure 22. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2016-2021)
Figure 23. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel in 2020
Figure 24. OTC Anti-Infective Products Revenue Market by Company in 2020 ($ Million)
Figure 25. Global OTC Anti-Infective Products Revenue Market Share by Company in 2020
Figure 26. Global OTC Anti-Infective Products Sales Market Share by Regions (2016-2021)
Figure 27. Global OTC Anti-Infective Products Revenue Market Share by Region in 2020
Figure 28. Americas OTC Anti-Infective Products Sales 2016-2021 (M Units)
Figure 29. Americas OTC Anti-Infective Products Revenue 2016-2021 ($ Millions)
Figure 30. APAC OTC Anti-Infective Products Sales 2016-2021 (M Units)
Figure 31. APAC OTC Anti-Infective Products Revenue 2016-2021 ($ Millions)
Figure 32. Europe OTC Anti-Infective Products Sales 2016-2021 (M Units)
Figure 33. Europe OTC Anti-Infective Products Revenue 2016-2021 ($ Millions)
Figure 34. Middle East & Africa OTC Anti-Infective Products Sales 2016-2021 (M Units)
Figure 35. Middle East & Africa OTC Anti-Infective Products Revenue 2016-2021 ($ Millions)
Figure 36. Americas OTC Anti-Infective Products Sales Market Share by Country in 2020
Figure 37. Americas OTC Anti-Infective Products Revenue Market Share by Country in 2020
Figure 38. Americas OTC Anti-Infective Products Sales Market Share by Type in 2020
Figure 39. Americas OTC Anti-Infective Products Sales Market Share by Sales Channel in 2020
Figure 40. United States OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 41. Canada OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 42. Mexico OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 43. Brazil OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 44. APAC OTC Anti-Infective Products Sales Market Share by Region in 2020
Figure 45. APAC OTC Anti-Infective Products Revenue Market Share by Regions in 2020
Figure 46. APAC OTC Anti-Infective Products Sales Market Share by Type in 2020
Figure 47. APAC OTC Anti-Infective Products Sales Market Share by Sales Channel in 2020
Figure 48. China OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 49. Japan OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 50. Korea OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 51. Southeast Asia OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 52. India OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 53. Australia OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 54. Europe OTC Anti-Infective Products Sales Market Share by Country in 2020
Figure 55. Europe OTC Anti-Infective Products Revenue Market Share by Country in 2020
Figure 56. Europe OTC Anti-Infective Products Sales Market Share by Type in 2020
Figure 57. Europe OTC Anti-Infective Products Sales Market Share by Sales Channel in 2020
Figure 58. Germany OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 59. France OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 60. UK OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 61. Italy OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 62. Russia OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 63. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Country in 2020
Figure 64. Middle East & Africa OTC Anti-Infective Products Revenue Market Share by Country in 2020
Figure 65. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Type in 2020
Figure 66. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Sales Channel in 2020
Figure 67. Egypt OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 68. South Africa OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 69. Israel OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 70. Turkey OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 71. GCC Country OTC Anti-Infective Products Revenue Growth 2016-2021 ($ Millions)
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
